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-------------------------------------------------------------------------------------------------------------~ 
The nevoid basal cell carcinoma syndrome is an autosomal 
dominant disorder characterized primarily by multiple basal 
cell carcinomas, odontogenic keratocysts, and pits of the 
palms and soles. Tumor deletion studies and linkage analysis 
in Caucasians have revealed that the gene is on chromosome 
9q. To further refine the location of the nevoid basal cell 
carcinoma syndrome locus, we tested linkage to this region in 
three families. Evaluation of recombinants suggested that the 
nevoid basal cell carcinoma syndrome locus lies in the inter-
val defined distally by D9S127. Our data, together with ex-
isting published data defining D9S12 as a proximal flanking 
marker, refine the location of nevoid basal cell carcinom~ 
syndrome to an 8.3-cM interval. Two of the families studieq 
were African-American and show a notable variation in phe, 
notypic expression in which affected individuals developeq 
few skin cancers. However, despite clinical heterogeneity. 
our data are consistent with the hypothesis that the sam\) 
locus is involved in these African-American families. K l). 
words: Gorlin Syndrome/basal cell nevus syfldrome/NBCCS/gell ~ 
mappittg//il"lkage atwlysis. ] In vest Dermatol 103:178-1 8 1, 
1994 
------------------------------------------------------------------------------------------------------------~ 
T he nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by multiple basal cell carcinomas, odontogenic kerato-cysts, pits of the palms and soles, and a variety of other . skeletal and developmental abnormalities. Linkage 
studies in several Caucasian families localized the NBCCS gene to 
chromosome 9q31 [1- 4], and the demonstration of allelic loss at 
this location in basal cell carcinomas from individuals with NBCCS 
indicated that the gene probably functions as a tumor suppressor [1). 
We have been studying NBCCS in two African-American families 
in which affected individuals developed few skin cancers, but fully 
expressed the other components of the disorder [5] . Once the gene is 
identified and characterized, these families may provide a resource 
for exploring whether the NBCCS gene in blacks is allelic to that in 
whites. Fine mapping of the 9q31 region will aid in defining the 
location of the NBCCS gene. To this end, we have performed 
genetic linkage analysis in these two families and a third family of 
Ashkenazi Jewish ances try. In this study we have confirmed and 
refined linkage of NBCCS using these families by developing new 
polymorphisms for D9S29 and utilizi.ng additional polymerase 
chain reaction - based DNA markers in the region. 
MATERIALS AND METHODS 
Families Clinical findings in the two African-American families are de-
scribed in detail elsewhere [5] and summarized here. The probands in these 
families (2587 and 3060) hadjaw cysts, palmar and plantar pits, rare basal cell 
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carcinomas, and significant NBCCS-associated skeletal anomalies. The af, 
fected relatives in these pedigrees hadjaw cysts and palmar pits. Half of th~ 
affected relatives had at least onc basal cell carcinoma. Many also had scolio-
sis, rib anomalies, or other skeletal findings. Pedigrees of these families an~ 
of the family of Ashkenazi-Jewish ancestry (N002), are shown in Fig 1. 
Family N002: The proband (II-I) was diagnosed at the age of2t years wit~ 
medulloblastoma and treated with x-ray therapy, and subsequently devel, 
oped basal cell carcinomas and cysts of the jaw at age 14. Invasion of basal cell 
tumors into the right ear canal, sal ivary gland, right petrous temporal bon~ 
occipital bone, and dura eventually led to his death at age 40. Family histol) 
revealed that 1-1 had multiple basal cell carcinomas and jaw cysts. w; 
examined the six offspring oBI-1. The oldest (llI-t) had twO jaw cysts at ag\ 
13, palmar and plantar pits, and typical facial features ofNBCCS. His sistet 
(III-2) , age 12, developed her first jaw C)(st at age 10 and basal cell carcino~ 
at age 11, and had palmar and plantar pits and calcification of the falx cereb~ 
on examination. IndividuaI1l1-3, age 10, had no history of jaw cysts or b~! 
cell carcinomas and showed none of the signs of NBCCS on dermatologi 
dental, radiographic, or ultrasound examinations. The fourth chi ld (II1-4j 
had ajaw cyst at age 8 and a basal cell carcinoma at age 9. He also had palm~ 
and plantar pits. Individual Ill-5, age 7, had no history ofNBCCS-associat~ 
findings, nor did our examination reveal anything suspicious for the diagn~ 
sis. The youngest child (IlI-6) was seen at age 6. She had palmar and plan I 
pits, a rib anomaly. and several probable periorbital basal ce ll carcinomas. 
DNA Marker Analysis DNA was purified from blood lymphocytes 
immortalized lymphocyte cell lines by standard procedures. Primer pairs f,\ 
amplifying microsatelJite length variants were as follows: G5N.PCR1. 1 
GSN.PCR1.2 for GSN(125-147bp) [6]; 9CMP2F/9CMP2R for D9S1 \ 
(149-159bp) [7); A28F/A28R for 095109 (219-229bp) [81 
D9S12.PCRl.l/D9S12.PCR1.2 for D9S12 (176-194bp) [9]; MX51 
MX58 for D9S15 (197-207bp) [10]; Mfd178CA/Mfd178GT for D9S10\ 
(187-203 bp), Mfd135CA/Mfd135GT for D9S53 (116 - 150 bp) a 
Mfd189CA/Mfd189GT for D9S106 (99-1 11 bp) [11]; C3B2-1/C3B2 ~ 
for D9S58 (113 -137 bp), D9S119.PCRl.l/ D9S119.PCR1.2 for D9511\ 
(130 -138 bp) [12]; and 2239-1/2239-2 for D9S59 (94-116 bp) [13]. 
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Figure 1. Pedigrees of three families with chromosome 9 haplotypes for 
members of each family. Families 2587 and 3060 arc African-American. 
Family N002 is AshkenaziJewish. Haplotypes were developed based on the 
order of markers shown. Because no recombination was observed between 
0951 96, 095180,095176, and 095173, a haplotype was created. This is 
indicated by a letter that stands for a unique allele combination (fourth locus 
from top) , -<, recombination between adjacent loci. >-, those loci in 
which phase could not be assigned definitively and hence the exact point of 
recombination could not be inferred. 5haded chromosome carries the 
NBCC5 disease gene in each family , Infe rred haplotypes and genotypes are 
in brackets. Arrow, proband for each family , No inferred information was 
used in the linkage analysis. ?, individual with ambiguous phenotype. This 
individual was not used for linkage analysis with NBCC5, 5ee text for 
details. 
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anonymous microsatellite markers 095196, 095180, 095176 and 095173 
were typed using the primers given in the Genethon Microsatellite Map 
Catalogue [14]. 5pecific primer sequences for all markers can be obtained 
from the Genome Data Base, Johns Hopkins University, Baltimore, MD. 
Genomic DNA (200 -500 ng) was amplified in a 30-1i1 reaction with 200 
nM primers, 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCI2 , 200 
liM each dATP, dGTP, and TTP, 25 mM dCTP, 1.5 IiCi 32P-dCTP 
(3000Ci/mmol) , and 0.75 U Taq po lymerase (Perkin Elmer Cetus). The 
thermal cycling protocol for all markers consisted of an initial 95 °C, 2 min 
denaturation, fo llowed by 35 cycles of denaturation at 93 °C for 1 min, 
annealing at 55 °C for 1 min, and elongation at 72°C for 1.5 min, and a final 
10 min at 72°C, For electrophoretic analysis, reaction volnmes were diluted 
1 : I with formamide, and the amplified DNA was separated on6% sequenc-
ing gels (6M urea) under standard electrophoretic conditions. 
Linkage Analysis The inheritance of NBCC5 was modeled as a rare, 
autosomal dominant disorder with full penetrance. Linkage analysis was 
performed using the computer program LINKAGE Version 5.1 on a VAX 
workstation. Two-poim (disease versus marker) lod scores were calculated 
using the MUNK subroutine for each marker versus the NBCC5 locus. In 
the absence of published allele frequency data for several of the markers used, 
alleles were assumed to be of equal frequency. Two five-point linkage analy-
ses (disease versus a fixed map of markers) were performed using the UNK-
MAP subroutine for the following map: 09512-5.2cM-095176-3.1 
cM - 095127-0,1 cM-09529-0.1 cM-095S3. The order of the 
markers is taken from published consensus maps for 09512, 095127, and 
09529 [1 5]' Our estimate, using linkage analysis in our famil ies, of the 
distances between these markers were somewhat different than those in 
Povey e/ al [15] . However, the distances in our famil ies were more consistent 
with those proposed by the recent International Workshop on Chromosome 
9 for 09512, 095176, 095127, and 09553 [16], No infonnation on dis-
tance between 09529 and other markers was provided in that study. The 
orientation of 09553 and 09529 is unresolved. In this study, we have placed 
09553 distal to 09529 as suggested in Goudie et al [17]. 
RESULTS 
Because the initial report of lin kage in NBCCS showed no recom-
bination w ith D9S29 [1) , it was important to obtain information 
with this marker in these fami lies. However, neither of the African-
America n families were informative for the previously reported 
TaqI RFLP. Screening with several restriction enzymes revealed 
polymorphism with BcoRV (McBride OW, in preparation), and 
both families 3060 and 2587 were informative with this enzyme/ 
probe combination. Interestingly, there was complete linkage dis-
equi librium between the TaqI and BcoRV polymorphisms in family 
N002. 
Using the BcoRV polymorphism in th e two African-American 
fami lies and the TaqI polymorphism in the Ashkenazi Jewish fam-
ily, linkage of the gene for N BCCS to D9S29 was confirmed 
(Z = 3.3; e = 0) , Family-specific lod scores fo r 14 chromosome 9 
markers are shown in Table 1. In addition to D9S29, there was no 
evidence of recombination in any of the fami lies from two-point 
analysis with D9S12 (Z = 3.9) , D9S196 (Z = 4,85), D9S180 
(Z = 3,9), D9S176 (Z = 5.29), and D9S173 (Z = 2.62) . Results for 
D9S15 and D9S119 have not been included in the table, as they 
were virtually uninformative, except in creating the haplotypes, 
To identify the most probable location for the NBCCS locus 
w ithin the map of linked m arkers, mu ltipoint analys is was per-
formed for D9S12, D9S176, D9S127, D9S29, and D9S53 and the 
disease. Due to computational limitations imposed by the large 
number of alleles for some markers, resu lts were derived by overlap-
ping two four-point analyses using the first four, and then the last 
four , markers, The order of the markers, and distances between 
th em , was based on previous reports and information from these 
families (see Methods). The maximum lod score (Z = 6.0) obtained 
from this analysis occurred coincident with D9S176. The next 
hi ghest lod score occurring dista l (away from the centromere) to 
D9S176 was 4.47 (8 cM dista l to D9S53, and outside of the map of 
markers used in the multipoint analys is) (Fig 2). 
We also performed haplotype analysis to further examine segre-
gation of the NBCCS gene in individuals w here recombination 
with the disease had occurred . The most probable chromosome 9 
haplotypes for each individual are shown in Fig 1, using the marker 
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Table I. Lod Scores for Each Family with 9q Markers 
Family 
09S12 
2587 
3060 
N002 
TOTAL 
09S196 
2587 
3060 
N002 
TOTAL 
09S180 
2587 
3060 
N002 
TOTAL 
095176 
2587 
3060 
N002 
TOTAL 
095173 
2587 
3060 
N002 
TOTAL 
095127 
2587 
3060 
N002 
TOTAL 
09S109 
2587 
3060 
N002 
TOTAL 
09S29 
2587 . 
3060 
N002 
TOTAL 
09S53 
2587 
3060 
N002 
TOTAL 
09S58 
2587 
3060 
N002 
TOTAL 
095105 
2587 
3060 
N002 
TOTAL 
09S106 
2587 
3060 
N002 
TOTAL 
09S59 
2587 
3060 
N002 
TOTAL 
GSN 
2587 
3060 
N002 
TOTAL 
0.001 
1.81 
2.10 
-0.01 
3.90 
1.80 
1.50 
1.53 
4.84 
2.70 
1.20 
3.91 
1.50 
2.58 
1.20 
5.28 
2.67 
-0.05 
2.62 
0.30 
- .29 
-0.03 
- .02 
-0.89 
-0.07 
-0.96 
1.20 
1.80 
0.30 
3.30 
1.50 
-1.58 
1.80 
1.72 
1.80 
-3.29 
1.80 
0.31 
1.20 
-0.03 
1.17 
1.50 
-3.29 
-0.03 
-1.82 
1.80 
-6.29 
-0.03 
-4.52 
-0.02 
-3.60 
- 1.19 
-4.81 
0.05 0.10 
1.65 1.48 
1.93 1.74 
-0.01 
3.57 3.22 
1.65 1.49 
1.37 1.23 
1.40 1.26 
4.43 3.98 
(Uninformative) 
2.49 2.25 
1.12 1.02 
3.60 3.27 
1.37 1.23 
2.37 2.14 
1.07 0.93 
4.81 4.30 
(Uninformative) 
2.45 2.22 
-0.05 -0.03 
2.41 2.19 
0.26 0.21 
1.21 1.30 
-0.01 
1.45 1.50 
(Uninformative) 
0.65 0.79 
-0.05 -0.03 
0.60 0.76 
1.09 0.98 
1.63 1.44 
0.26 0.21 
2.98 2.63 
1.37 1.23 
0.02 0.20 
1.67 1.53 
3.06 2.96 
1.65 1.48 
-0.07 0.34 
1.67 1.53 
3.25 3.36 
1.09 0.98 
(Uninformative) 
-0.03 -0.03 
1.06 0.95 
1.37 
-0.07 
-0.03 
1.27 
1.65 
-1.35 
-0.02 
0.28 
0.46 
-0.35 
0.39 
0.51 
1.23 
0.34 
-0.02 
1.55 
1.48 
-0.61 
-0.02 
0.85 
0.57 
0.09 
0.58 
1.24 
0.15 
1.31 
1.54 
2.85 
1.31 
1.08 
1.11 
3.51 
2.00 
0.92 
2.93 
1.08 
1.90 
0.78 
3.77 
1.97 
-0.02 
1.96 
0.17 
1.25 
1.42 
0.79 
-0.02 
0.77 
0 .85 
1.24 
0.17 
2.26 
1.08 
0.26 
1.38 
2.72 
1.31 
0.50 
1.38 
3.19 
0.85 
-0.01 
0.84 
1.08 
0 .50 
-om 
1.57 
1.31 
-0.24 
-0.01 
1.06 
0 .58 
0.28 
0.63 
1.49 
3.90 
4.85 
3.91 
5.29 
2.62 
1.50 
0.78 
3.31 
3.06 
3.40 
1.17 
1.58 
1.10 
1.53 
o 
o 
o 
o 
o 
0.09 
0.14 
o 
0.06 
0.09 
o 
0.13 
0 .18 
0.18 
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Figure 2. Multipoint linkage analysis in three families of NBCCS versus a 
map of five polymorphic DNA markers on chromosome 9q. 
order discussed above and indicated in the figure. Diagnosis of indi-
vidual Il-2 in family 3060 was uncertain [5], and he was considered 
unknown for linkage analysis. Because his affected mother was 
homozygous for markers proximal (toward the centromere) to 
D9S12, we cannot determine if he inherited an intact disease chro-
mosome. 
DISCUSSION 
There are clinical differences in the presentation of NBCCS be-
tween Blacks and Caucasians, as described by Goldstein et af [5] . 
Specifically, African-Americans with this disease have far fewer 
skin cancers than affected Caucasians, with possible exacerbation of 
the extra-cutaneous manifestations of the disease. However, it is 
clear from the data presented here that the gene for NBCCS local-
izes to the same region on 9q in both Blacks and Caucasians, and is 
likely to be due to the same locus. The clinica l differences may be 
accounted for by different alleles at the same locus (i.e., different 
mutations in the NBCCS gene), or differences in the genetic back-
ground on which the NBCCS gene is expressed (i.e., genes for 
pigmentation) . 
Our data are consistent with the oider of markers on chromosome 
9q being cen- D9S12- [D9S 176,D9S180,D9S173,D9S196]-
[D9S127,D9S109]-[D9S29,D9S53]-D9S58-tel. We ob-
served no recombination between D9S127 and D9S109; no recom-
bination between D9S176, D9S180, D9S173, and D9S196; and no 
recombination between D9S29 and D9S53. However, Goudie et af 
[17] state that the order cen-D9S29-D9S53-tel is 100 times 
more likely than the inverse order, and we have thus placed D9S29 
proximal to D9S53 for the multipoint linkage analysis. 
Our data establish D9S 127 as a distal flanking marker to NBCCS, 
based substantially on the haplotype for unaffected individual II-S 
of family 3060 (Fig 1 C). This individual accounts for the single 
recombination between the NBCCS gene and D9S127, D9S109, 
and D9S53 identified by two-point linkage analysis. The parental 
genotypes for D9S29 were uninformative, both parents being 2-1 at 
this locus; therefore two-point analysis was unable to identify a 
recombination. However, the disease haplotype was present in II-S 
for all markers distal to the cosegregating group of D9S196, 
D9S180, D9S176, D9S173, and therefore recombination with 
D9S29 in this individual is probable. As this individual had none of 
the findings associated with NBCCS upon examination, the impli-
cation is that the NBCCS locus must lie proximal to D9S127. 
A proximal flanking marker to the NBCCS gene cannot be de-
rived from the two-point linkage analysis in these families because 
D9S12 showed complete linkage with NBCCS, and we have there-
fore constructed conservative haplotypes (where recombination 
occurs on the non-disease chromosome) consistent with this anal)" 
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sis. However, alternative haplotypes of individuals III-2 and III-S in 
family N002 can be derived that invoke recombination distal to 
D9S 12 on the paternally derived disease chromosome. For example, 
in affected person II1-2, the alternative haplotype with the recombi-
nation occurring between D9S12 and distal markers places the 
NBCCS locus distal to D9S12. Such an event has been previously 
reported in other families [2,3]. 
These data, taken together, place the NBCCS locus proximal to 
D9S 127. Evidence from other studies [3,18] and haplotyping in 
N002 in this paper support assignment of D9S12 as a proximal 
flanking marker. Our data, therefore, define an 8.3-cM interval 
around the NBCCS locus. The markers D9S127 and D9S12, to-
gether with D9S 176, D9S 196, and D9S 180, will be extremely use-
ful in prenatal. diagnosis. in informat!ve f~milies, and for further 
physical mapp1l1g strategies aimed at Isolat1l1g the NBCCS gene. 
We wish to ackllowledge the cotltitJlled participatiotl oj the Jamilies itlvolved itJ tlris 
study and tire NBCC Patietl/ SIIJ!port GrollJ! (Mrs. Petlelope Fischer, ExeCII/ive 
Director). Thanks are dlle to Ron Kase, RN (Westat, ItIC.) and Salldra Santllcci, 
RN (N.I.A .M.S.) Jor IlIIrsing sllpport. 
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